Probi, Symrise launch probiotic-based skincare ingredient, SymFerment
Probi, in collaboration with Symrise, created a new skincare ingredient, SymFerment, a moisturizing active ingredient based on a byproduct from Probi’s probiotic derived from the fermentation of Lactiplantibacillus (Lactobacillus).
Photo © iStockphoto.com/Osuleo
Probi (Lund, Sweden), in collaboration with Symrise, created a new skincare ingredient, SymFerment, a moisturizing active ingredient based on a byproduct from Probi’s probioticderived from the fermentation of Lactiplantibacillus (Lactobacillus).
“By using a by-product from our regular production, our waste is upcycled and processed into new products,” said Andy McShea, COO, Probi, in a press release. “Part of the amount of water we use in production can therefore be reused. This is not only good for our gross margins in production but for use of resources in terms of water consumption.”
“Consumers are increasingly asking for sustainable cosmetic products,” says Léa Schmidt, global product manager at Symrise. “That’s why sustainability always forms the heart of our product development efforts. Thanks to the partnership with Probi, we can use valuable by-products from the production of probiotics to create effective ingredients such as SymFerment.”
Symrise will present the ingredient at in-cosmetic Global trade fair in Paris in April 2022.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
